Ishani Nath / en Do you have questions about children's vaccines? A new phone line has the answers /news/do-you-have-questions-about-children-s-vaccines-new-phone-line-has-answers <span class="field field--name-title field--type-string field--label-hidden">Do you have questions about children's vaccines? A new phone line has the answers</span> <div class="field field--name-field-featured-picture field--type-image field--label-hidden field__item"> <img loading="eager" srcset="/sites/default/files/styles/news_banner_370/public/2024-01/GettyImages-1186116332-crop.jpg?h=81d682ee&amp;itok=w4ogJNpT 370w, /sites/default/files/styles/news_banner_740/public/2024-01/GettyImages-1186116332-crop.jpg?h=81d682ee&amp;itok=QPraweJ5 740w, /sites/default/files/styles/news_banner_1110/public/2024-01/GettyImages-1186116332-crop.jpg?h=81d682ee&amp;itok=wG9PHgG1 1110w" sizes="(min-width:1200px) 1110px, (max-width: 1199px) 80vw, (max-width: 767px) 90vw, (max-width: 575px) 95vw" width="740" height="494" src="/sites/default/files/styles/news_banner_370/public/2024-01/GettyImages-1186116332-crop.jpg?h=81d682ee&amp;itok=w4ogJNpT" alt="Mother looking at a cellphone while taking care of infant son"> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span>Christopher.Sorensen</span></span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2024-02-05T09:18:11-05:00" title="Monday, February 5, 2024 - 09:18" class="datetime">Mon, 02/05/2024 - 09:18</time> </span> <div class="clearfix text-formatted field field--name-field-cutline-long field--type-text-long field--label-above"> <div class="field__label">Cutline</div> <div class="field__item"><p><em>(photo by SDI Productions/Getty Images)</em></p> </div> </div> <div class="field field--name-field-author-reporters field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/authors-reporters/ishani-nath" hreflang="en">Ishani Nath</a></div> </div> <div class="field field--name-field-topic field--type-entity-reference field--label-above"> <div class="field__label">Topic</div> <div class="field__item"><a href="/news/topics/our-community" hreflang="en">Our Community</a></div> </div> <div class="field field--name-field-story-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/tags/centre-vaccine-preventable-diseases" hreflang="en">Centre for Vaccine Preventable Diseases</a></div> <div class="field__item"><a href="/news/tags/temerty-faculty-medicine" hreflang="en">Temerty Faculty of Medicine</a></div> <div class="field__item"><a href="/news/tags/pediatrics" hreflang="en">Pediatrics</a></div> <div class="field__item"><a href="/news/tags/dalla-lana-school-public-health" hreflang="en">Dalla Lana School of Public Health</a></div> <div class="field__item"><a href="/news/tags/hospital-sick-children" hreflang="en">Hospital for Sick Children</a></div> <div class="field__item"><a href="/news/tags/vaccines" hreflang="en">Vaccines</a></div> </div> <div class="field field--name-field-subheadline field--type-string-long field--label-above"> <div class="field__label">Subheadline</div> <div class="field__item">The SickKids Vaccine Consult Service (VCS) aims to answer caregivers’ questions about all pediatric vaccinations</div> </div> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>Canada is in the midst of respiratory illness season, yet the number of individuals getting the updated COVID-19 and flu vaccines remains low. The number of children receiving routine vaccinations <a href="https://www.dlsph.utoronto.ca/2023/04/21/unicef-routine-childhood-immunization-report-2023-cvpd-shelly-bolotin/">has also&nbsp;dropped since the pandemic</a>.</p> <p>For the past few years, questions about vaccines dominated headlines and internet searches. Is this vaccine safe? Will it work? Who needs to get vaccinated?</p> <p><strong>Shaun Morris,</strong>&nbsp;a clinician scientist&nbsp;at The Hospital for Sick Children (SickKids) and an associate professor of pediatrics in the Ƶ’s Temerty Faculty of Medicine, and&nbsp;<strong>Pierre-Philippe Piché-Renaud</strong>, who is pursuing a clinical and research fellowship at SickKids and graduate studies at U of T’s&nbsp;Dalla Lana School of Public Health,&nbsp;routinely field these types of questions from parents and caregivers.</p> <p>Both are members of the&nbsp;<a href="https://www.dlsph.utoronto.ca/institutes/centre-for-vaccine-preventable-diseases/">Centre for Vaccine Preventable Diseases</a> (CVPD)&nbsp;at the Dalla Lana School of Public Health.</p> <figure role="group" class="caption caption-drupal-media align-left"> <div> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <img loading="lazy" src="/sites/default/files/2024-01/morris-renaud_0.jpg" width="350" height="175" alt="&quot;&quot;"> </div> </div> <figcaption><em>Shaun Morris and Pierre-Philippe Piché-Renaud (supplied images)</em></figcaption> </figure> <p>To help boost confidence in vaccination through easy access to reliable, evidence-based information, Morris and Piché-Renaud have launched a new pilot project running until the end of March.&nbsp;</p> <p><a href="https://www.sickkids.ca/en/care-services/support-services/vaccine-consult-service/">The SickKids Vaccine Consult Service</a> (VCS), part of a larger project funded by the Public Health Agency of Canada (PHAC), is offering a phone service staffed by nurses to answer caregivers’ questions about all pediatric vaccinations. The intent is to make vaccine information more accessible and, ultimately, help parents make the best, most informed decision for their child, Piché-Renaud says.</p> <p>&nbsp;</p> <h4>Building on previous success</h4> <p>The pilot project builds off the success of a COVID-19-specific VCS phone line that ran from October 2021 to March 2023. The COVID-19 VCS received more than 2,700 calls from caregivers asking about COVID-19 vaccines for children. The phone line was staffed by health-care professionals who provided information tailored to each individual circumstance, including living situation or medical history – answers that could not typically be found on the internet.</p> <p>The nurses fielding calls were trained to create an open and safe environment, explains&nbsp;<strong>Julia Orkin</strong>, the SickKids COVID-19 VCS medical lead and an associate professor in U of T’s department of paediatrics in the Temerty Faculty of Medicine.</p> <p>“It wasn’t, you know, ‘you must do this,’ it was really a shared supportive conversation,” she says. After calling in, 83 per cent of caregivers surveyed said their questions and concerns were addressed, and more than 60 per cent said they would proceed with vaccination.</p> <p>The new phone service expands beyond the COVID-19 VCS by fielding questions not only about COVID-19 vaccines but all childhood immunizations. The service is open to anyone in Ontario, with a specific focus on patients with existing medical concerns and equity-deserving populations throughout the Greater Toronto Area.</p> <p>Insurance coverage and internet access aren’t required to book a VCS consultation and translation services are available.</p> <p>Piché-Renaud says that the conversations are about “taking it one step at a time, meeting parents where they are, and addressing their concerns.”</p> <p>Research has shown that COVID-19 vaccine uptake was&nbsp;lower&nbsp;among certain groups – for instance, certain racialized and lower income populations. To reach these communities, Morris and Piché-Renaud are working with organizations like&nbsp;<a href="https://www.bcchc.com/">Black Creek Community Health Centre</a>,&nbsp;<a href="https://www.taibuchc.ca/en/">Taibu Community Health Centre</a>&nbsp;and the Paediatric Alliance of Ontario.</p> <p>“The messaging is going to come through the people that [caregivers in these communities] already know and work with,” says Piché-Renaud.</p> <h4>Meeting an urgent need</h4> <p>Providing information on the importance of childhood vaccinations is particularly urgent.</p> <p>“Immunization coverage for a variety of diseases is lagging behind, leaving kids susceptible to infections and outbreaks that are completely preventable. It’s essential to provide parents with clear, individually tailored messaging from a trusted source to enable them to make informed decisions for their children,” says&nbsp;<strong>Shelly Bolotin</strong>, director of the Centre for Vaccine Preventable Diseases and an associate professor at the Dalla Lana School of Public Health.</p> <p>During the pandemic, routine childhood immunizations for preventable diseases like meningitis, measles and polio were set back to&nbsp;levels not seen since 2008. The proportion of Canadians who view vaccines as important for children also dropped from 91 to 82 per cent, according to&nbsp;<a href="https://www.unicef.org/reports/state-worlds-children-2023" target="_blank">UNICEF’s 2023 State of the World’s Children</a> report. Canada has since seen cases of&nbsp;pertussis (whooping cough)&nbsp;and&nbsp;other vaccine preventable diseases.</p> <p>“We’re still seeing kids who show up at SickKids and other paediatric hospitals with vaccine preventable illnesses, like certain types of meningitis,” says Piché-Renaud.</p> <p>The physicians hope that through the VCS phone line and a related project working with SickKids pediatricians and patients, they will be able to better understand why some children are not getting vaccinated. With this information, they can then develop resources such as educational websites, or improve access to vaccination sites.</p> <h4>Making trusted vaccine information more accessible</h4> <p>Morris and Piché-Renaud encourage Ontario parents wondering about childhood vaccines to <a href="https://www.sickkids.ca/en/care-services/support-services/vaccine-consult-service/">book a consultation appointment at SickKids VCS</a>.</p> <p>For Morris, empowering patients and families to make the best health decisions for themselves is one of the most important aspects of his job. Services like the VCS phone line help achieve that goal by “enabling people to connect to trusted sources of information and navigate through the quagmire of not good information, which is probably more common in the realm of immunization than in most areas.”</p> </div> <div class="field field--name-field-news-home-page-banner field--type-boolean field--label-above"> <div class="field__label">News home page banner</div> <div class="field__item">Off</div> </div> Mon, 05 Feb 2024 14:18:11 +0000 Christopher.Sorensen 305803 at Infants are vulnerable to chickenpox earlier than previously thought: Study /news/infants-are-vulnerable-chickenpox-earlier-previously-assumed-study <span class="field field--name-title field--type-string field--label-hidden">Infants are vulnerable to chickenpox earlier than previously thought: Study</span> <div class="field field--name-field-featured-picture field--type-image field--label-hidden field__item"> <img loading="eager" srcset="/sites/default/files/styles/news_banner_370/public/2023-11/GettyImages-1183048880-crop.jpg?h=afdc3185&amp;itok=gntaNLmS 370w, /sites/default/files/styles/news_banner_740/public/2023-11/GettyImages-1183048880-crop.jpg?h=afdc3185&amp;itok=hQoNaxt3 740w, /sites/default/files/styles/news_banner_1110/public/2023-11/GettyImages-1183048880-crop.jpg?h=afdc3185&amp;itok=L1s6ZQGA 1110w" sizes="(min-width:1200px) 1110px, (max-width: 1199px) 80vw, (max-width: 767px) 90vw, (max-width: 575px) 95vw" width="740" height="494" src="/sites/default/files/styles/news_banner_370/public/2023-11/GettyImages-1183048880-crop.jpg?h=afdc3185&amp;itok=gntaNLmS" alt="infant with chickenpox receives some ointment from their mother"> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span>Christopher.Sorensen</span></span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2023-11-24T11:57:43-05:00" title="Friday, November 24, 2023 - 11:57" class="datetime">Fri, 11/24/2023 - 11:57</time> </span> <div class="clearfix text-formatted field field--name-field-cutline-long field--type-text-long field--label-above"> <div class="field__label">Cutline</div> <div class="field__item"><p><em>(photo by&nbsp;Mixmike/Getty Images)</em></p> </div> </div> <div class="field field--name-field-author-reporters field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/authors-reporters/ishani-nath" hreflang="en">Ishani Nath</a></div> </div> <div class="field field--name-field-topic field--type-entity-reference field--label-above"> <div class="field__label">Topic</div> <div class="field__item"><a href="/news/topics/breaking-research" hreflang="en">Breaking Research</a></div> </div> <div class="field field--name-field-story-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/tags/temerty-faculty-medicine" hreflang="en">Temerty Faculty of Medicine</a></div> <div class="field__item"><a href="/news/tags/dalla-lana-school-public-health" hreflang="en">Dalla Lana School of Public Health</a></div> <div class="field__item"><a href="/news/tags/hospital-sick-children" hreflang="en">Hospital for Sick Children</a></div> <div class="field__item"><a href="/news/tags/research-innovation" hreflang="en">Research &amp; Innovation</a></div> </div> <div class="field field--name-field-subheadline field--type-string-long field--label-above"> <div class="field__label">Subheadline</div> <div class="field__item">The findings are in line with previous&nbsp;research&nbsp;indicating that the level of antibodies babies receive from their mothers at birth wear off quickly</div> </div> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>Infants are not protected against the varicella-zoster virus, the virus that causes chickenpox, for several months before they are eligible for vaccination, a new study has found.</p> <p>In some cases, infants may be at risk of infection as early as one month after they are born.</p> <p>“Antibodies transferred through the placenta during pregnancy protect babies against many infectious diseases when they are born, including the varicella virus,” says Associate Professor&nbsp;<strong>Shelly Bolotin</strong>, director of the Ƶ’s <a href="https://www.dlsph.utoronto.ca/institutes/centre-for-vaccine-preventable-diseases/">Centre for Vaccine Preventable Diseases</a>&nbsp;(CVPD)&nbsp;at the Dalla Lana School of Public Health and the study’s first author.</p> <p>“However, our research found that that protection fades quickly, leaving infants vulnerable to infection for many months before they are eligible for chickenpox vaccine, which in Ontario is given at age 15 months.”</p> <p>Using samples collected at The Hospital for Sick Children (SickKids) in Toronto, researchers looked at the antibody levels in blood samples from 187 infants up to one year of age. They found that antibodies protecting against varicella wore off quickly, and that almost 80 per cent of infants were susceptible to infection by the time they were three months old. At six months, all the infants studied were susceptible to chickenpox infection.</p> <p>The findings, <a href="https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0287765">published in the journal PLOS One</a>, are in line with previous&nbsp;research&nbsp;indicating that the level of antibodies babies receive from their mothers at birth wear off quickly.</p> <p>“Although many people think of chickenpox as a mild childhood infection, and it generally is, it can cause complications like skin infections, pneumonia or inflammation of the brain, particularly in young children,” says senior study author and CVPD member&nbsp;<strong>Michelle Science</strong>, an infectious disease consultant and medical adviser for infection prevention and control at SickKids.</p> <p>Science, who is also an assistant professor in the Temerty Faculty of Medicine, notes that infants are at a higher risk of complications than older children, and are the most likely age group to be hospitalized. Prior to the vaccine’s availability, Canada saw&nbsp;approximately&nbsp;350,000 varicella cases per year with 1,500 people hospitalized annually.</p> <p>The chickenpox vaccine helps protect individuals from infection as well as the serious complications that can occur. Getting vaccinated also helps lower the number of cases of chickenpox in all age-groups in a community&nbsp;– even in those too young or too old to be vaccinated.</p> <p>The chickenpox vaccine is already part of routine childhood vaccination in several countries, including Canada, Australia, Germany and the United States. In the U.K., <a href="https://www.gov.uk/government/publications/childhood-varicella-vaccination-programme-jcvi-advice-14-november-2023/jcvi-statement-on-a-childhood-varicella-chickenpox-vaccination-programme">the Joint Committee on Vaccination and Immunization recently&nbsp;recommended</a>&nbsp;that a chickenpox vaccine program should be introduced into the routine childhood immunization schedule, and that a catch-up program for older children should also be implemented in the future.</p> <p>“The results of our study confirm that everyone around an infant should be protected from chickenpox, either because they were previously infected or through vaccination,” says Science.</p> <p>She adds that these results may be helpful for both parents and health-care providers, who should be thinking about varicella whenever they see a rash, even in a young baby, and in the assessment of an infant’s risk of infection if they are exposed to a case.</p> <p>Bolotin and her co-authors noted that more research is needed on varying demographics and whether factors like breastfeeding or a mother’s age influence their baby’s antibody levels.</p> <p>In the meantime, this study is a reminder of the importance of immunizations.</p> <p>“Vaccination is not only about protecting yourself, it’s also about protecting your family, friends, and neighbours,” says Bolotin. “Our study further affirms how getting vaccinated can protect some of the most vulnerable – and in this case, the newest&nbsp;– members of our society.”</p> </div> <div class="field field--name-field-news-home-page-banner field--type-boolean field--label-above"> <div class="field__label">News home page banner</div> <div class="field__item">Off</div> </div> Fri, 24 Nov 2023 16:57:43 +0000 Christopher.Sorensen 304642 at BlueDot is using AI to get ahead of the next pandemic /news/bluedot-using-ai-get-ahead-next-pandemic <span class="field field--name-title field--type-string field--label-hidden">BlueDot is using AI to get ahead of the next pandemic</span> <div class="field field--name-field-featured-picture field--type-image field--label-hidden field__item"> <img loading="eager" srcset="/sites/default/files/styles/news_banner_370/public/2023-08/GettyImages-1201732416-crop.jpg?h=afdc3185&amp;itok=cJ-U9vqs 370w, /sites/default/files/styles/news_banner_740/public/2023-08/GettyImages-1201732416-crop.jpg?h=afdc3185&amp;itok=ya46BXKQ 740w, /sites/default/files/styles/news_banner_1110/public/2023-08/GettyImages-1201732416-crop.jpg?h=afdc3185&amp;itok=9bw3vJ1y 1110w" sizes="(min-width:1200px) 1110px, (max-width: 1199px) 80vw, (max-width: 767px) 90vw, (max-width: 575px) 95vw" width="740" height="494" src="/sites/default/files/styles/news_banner_370/public/2023-08/GettyImages-1201732416-crop.jpg?h=afdc3185&amp;itok=cJ-U9vqs" alt="&quot;&quot;"> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span>Christopher.Sorensen</span></span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2023-08-15T14:11:56-04:00" title="Tuesday, August 15, 2023 - 14:11" class="datetime">Tue, 08/15/2023 - 14:11</time> </span> <div class="clearfix text-formatted field field--name-field-cutline-long field--type-text-long field--label-above"> <div class="field__label">Cutline</div> <div class="field__item"><p>Kamran Khan, founder and CEO of BlueDot, is a scientist at Unity Health Toronto and a professor in the department of medicine in the Ƶ’s Temerty Faculty of Medicine and the Dalla Lana School of Public Health&nbsp;<em>(photo by JORGE UZON/AFP via Getty Images)</em></p> </div> </div> <div class="field field--name-field-author-reporters field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/authors-reporters/ishani-nath" hreflang="en">Ishani Nath</a></div> </div> <div class="field field--name-field-story-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/tags/centre-vaccine-preventable-diseases" hreflang="en">Centre for Vaccine Preventable Diseases</a></div> <div class="field__item"><a href="/news/tags/temerty-faculty-medicine" hreflang="en">Temerty Faculty of Medicine</a></div> <div class="field__item"><a href="/news/tags/artificial-intelligence" hreflang="en">Artificial Intelligence</a></div> <div class="field__item"><a href="/news/tags/dalla-lana-school-public-health" hreflang="en">Dalla Lana School of Public Health</a></div> <div class="field__item"><a href="/news/tags/global" hreflang="en">Global</a></div> </div> <div class="field field--name-field-subheadline field--type-string-long field--label-above"> <div class="field__label">Subheadline</div> <div class="field__item">Startup's data-driven forecasts extend as far as 10 years into the future</div> </div> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>The Toronto offices for <strong>Kamran Khan</strong>’s <a href="https://bluedot.global/">BlueDot</a>, which uses artificial intelligence to flag potential infectious disease outbreaks around the world, are located at the edge of Lake Ontario – appropriate for a company that, similar to a lighthouse, signals when there’s danger ahead.</p> <p>“We use the internet as a medium for surveillance to detect early signals of outbreaks anywhere in the world before they’re officially reported by public health agencies,” explains Khan, a scientist at Unity Health Toronto and a professor in the department of medicine in the Ƶ’s Temerty Faculty of Medicine and the Dalla Lana School of Public Health.</p> <p>He breaks BlueDot’s work down into three key components: identifying threats early, rapidly assessing their risks and likely trajectories, and helping organizations to turn these insights into swift action.</p> <p>“The whole purpose here is to compress time, because ultimately, time is the enemy when you’re dealing with an outbreak,” says Khan, a member of U of T’s <a href="https://www.dlsph.utoronto.ca/institutes/centre-for-vaccine-preventable-diseases/">Centre for Vaccine Preventable Diseases</a>.</p> <p>BlueDot’s intelligence platform combines a computer’s ability to understand human language, known as natural language understanding (NLU), and machine learning, a form of AI that imitates humans’ ability to learn and gradually become more accurate. The platform sorts through massive volumes of online information&nbsp;– ranging from news reports, social media sites, government websites, and more – from around the globe, in more than 130 languages, every 15 minutes of every day.</p> <p>“We’ve basically trained a machine to pick up early clues around the world and around the clock,” explains Khan.</p> <p>The clues get cross-referenced with historic data to determine what is outside of the norm, and then triaged into high, medium and low risk threats. Global data – including commercial air travel data, climate conditions, mosquito observances and population demographics – are also added to the mix to determine whether a threat could spread.</p> <p>This data analytic sequence is how BlueDot accurately predicted a Zika virus outbreak in Florida six months before it occurred, and <a href="/news/u-t-s-kamran-khan-how-his-startup-used-ai-spot-coronavirus-anyone-else-cnbc">sounded the alarm about COVID-19</a> nearly a week before it was officially reported by public health organizations like the CDC and WHO.</p> <p>As COVID-19 restrictions have eased around the world, public health experts are now shifting focus to the next set of emerging global threats – what could spark the next pandemic, and will we be ready? Writer <strong>Ishani Nath</strong> sat down with Khan to learn how BlueDot uses artificial and human intelligence to help answer these questions and more.</p> <hr> <p><strong>How does BlueDot work – is it all done by machines or do humans play a role?</strong></p> <p>Our belief is that machines should play to their strengths, and humans should play to their own. There’s a whole process of using machine learning for gathering, organizing and ingesting unstructured data that’s multilingual and creating structure out of it 24 hours a day, 365 days a year. And then there’s a series of analytics and human intelligence that helps us differentiate what threats demand our immediate attention and anticipate where, when, and how they will impact the health of populations around the globe. Recent advances in generative AI are also creating opportunities for machines to produce “intelligence briefs” – but given the vital importance of these outputs, there will always be a need for human oversight.</p> <p>For example, we first have to determine whether a threat appearing somewhere in the world is unusual. It’s important to remember that machine learning is only as good as the historic data that we train it on. But when we’re dealing with newly emerging diseases, we are often dealing with threats where there is little or no historic data. For instance, if we identify an outbreak of an influenza-like illness occurring in the Northern Hemisphere in July, we know that is unusual compared with observed historic trends. But for some newly emerging threats like COVID-19&nbsp;– where we don’t have historic data&nbsp;– we have to tap into our in-house expertise in public health sciences, clinical medicine, pediatric infectious disease and veterinary sciences, while also collaborating with experts from academia and governments around the world to rapidly characterize and assess those novel threats.</p> <figure role="group" class="caption caption-drupal-media align-left"> <div> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <img loading="lazy" src="/sites/default/files/2023-08/2-crop.jpg" width="350" height="547" alt="&quot;&quot;"> </div> </div> <figcaption><em>Notable Event Alert screenshot from BlueDot (supplied image)</em></figcaption> </figure> <p><strong>When it comes to vaccines, how can this information improve which threats get addressed?</strong></p> <p>Well, we’re not just considering what constitutes a vaccine-preventable disease today. By working with private sector organizations like pharmaceutical companies, we’re helping support decisions about what they should be investing in in terms of R&amp;D to develop new vaccines for diseases where the landscape is going to significantly change in the future&nbsp;– for example, because of climate change.</p> <p>And when vaccines are in market, are they manufacturing enough in relation to forthcoming demand? Are they producing it at the right time? Are they distributing it optimally and equitably? BlueDot’s public and private sector clients are using our intelligence to support key decisions&nbsp;– not just about what’s happening now, but also what’s coming next.</p> <p><strong>You mentioned climate change. Do you also consider climate and environmental data?</strong></p> <p>Yes. Going back to Zika for example&nbsp;– what we were able to determine and <a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)00080-5/fulltext">publish in&nbsp;<em>the Lancet</em></a>&nbsp;is where we would expect lots of infected travellers and no local outbreak versus lots of infected travellers, as well as environmental conditions suitable for a local outbreak. What happened six months later is entirely aligned with what we anticipated.</p> <p>We’re now working on taking the latest climate change models and intersecting them with ecological models for mosquitoes and insects so we can anticipate where those insects will survive and thrive in new areas. If you don’t have the mosquito that can transmit a particular virus, then there’s no possibility of a local outbreak from that virus. But these ranges are changing. In some cases, it’s actually becoming too hot and they’re not able to effectively transmit. But in other cases, conditions are becoming more hospitable.</p> <p><strong>How far into the future do these forecasts extend?</strong></p> <p>We’re doing these forecasts looking 10 years into the future. The main reason we’re looking out that far, realizing there’s more uncertainty as you go further out, is that we are working with pharmaceutical and life sciences companies that develop and manufacture vaccines, therapeutics, diagnostics, PPE, disinfectants and more. Their interests are understanding and anticipating future demand. Do they invest in a chikungunya vaccine or a vaccine for a different infectious disease? A vaccine manufacturer has to consider: What am I investing in today, how many lives could it protect and is this a sound business decision recognizing that it might take a decade or more to actually bring that vaccine to market?</p> <p><strong>What’s next for BlueDot?</strong></p> <p>Building on top of large language models (LLMs) like GPT, we’ve developed some early capabilities where you can ask our platform questions in natural language. Like, “Every day, tell me how many cases of COVID there are in my location this week and if there’s an increase of 10 per cent or more above baseline, notify me.” Or, “Tell me how many travellers on flights are coming from London to Toronto in the next three months and the likelihood of an imported case of measles showing up.” We’re still actively in R&amp;D mode but building on top of LLMs is showing a lot of promise.</p> <p><strong>How does working in this space shape how you personally feel about the future?</strong></p> <p>I’m excited by the fact that technology can help humans in powerful ways, but understand that humans have to help themselves. I often quote the Spanish-American philosopher George Santayana who said, “Those who cannot remember the past are condemned to repeat it.” My worry is we’re quick to forget and that we will repeat the cycle of panic followed by neglect until humanity realizes we have to be proactive – because we know it’s a certainty we will be dealing with more threats in the future. What I often ask myself is, what things can I do today that will have a tangible and positive impact on the lives of others?</p> <p><em>This interview has been edited and condensed for clarity.</em></p> <h3><a href="https://www.ctvnews.ca/health/ai-could-help-predict-the-next-pandemic-but-proper-guardrails-are-needed-experts-1.6518112?autoPlay=true">Read more about BlueDot at CTV News</a></h3> <p>&nbsp;</p> <p>&nbsp;</p> </div> <div class="field field--name-field-news-home-page-banner field--type-boolean field--label-above"> <div class="field__label">News home page banner</div> <div class="field__item">Off</div> </div> Tue, 15 Aug 2023 18:11:56 +0000 Christopher.Sorensen 302629 at Research aims to help parents prepare for RSV immunizations for children /news/research-aims-help-parents-prepare-rsv-immunizations-children <span class="field field--name-title field--type-string field--label-hidden">Research aims to help parents prepare for RSV immunizations for children</span> <div class="field field--name-field-featured-picture field--type-image field--label-hidden field__item"> <img loading="eager" srcset="/sites/default/files/styles/news_banner_370/public/2023-07/GettyImages-1305883979-crop.jpg?h=afdc3185&amp;itok=IK46wESy 370w, /sites/default/files/styles/news_banner_740/public/2023-07/GettyImages-1305883979-crop.jpg?h=afdc3185&amp;itok=JfpNrjqe 740w, /sites/default/files/styles/news_banner_1110/public/2023-07/GettyImages-1305883979-crop.jpg?h=afdc3185&amp;itok=0DRk-bmS 1110w" sizes="(min-width:1200px) 1110px, (max-width: 1199px) 80vw, (max-width: 767px) 90vw, (max-width: 575px) 95vw" width="740" height="494" src="/sites/default/files/styles/news_banner_370/public/2023-07/GettyImages-1305883979-crop.jpg?h=afdc3185&amp;itok=IK46wESy" alt="a doctor prepares an infant girl's arm with a cotton swab for a vaccination"> </div> <span class="field field--name-uid field--type-entity-reference field--label-hidden"><span>siddiq22</span></span> <span class="field field--name-created field--type-created field--label-hidden"><time datetime="2023-07-19T14:50:09-04:00" title="Wednesday, July 19, 2023 - 14:50" class="datetime">Wed, 07/19/2023 - 14:50</time> </span> <div class="clearfix text-formatted field field--name-field-cutline-long field--type-text-long field--label-above"> <div class="field__label">Cutline</div> <div class="field__item"><p><em>(photo by FatCamera/Getty Images)</em></p> </div> </div> <div class="field field--name-field-author-reporters field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/authors-reporters/ishani-nath" hreflang="en">Ishani Nath</a></div> </div> <div class="field field--name-field-topic field--type-entity-reference field--label-above"> <div class="field__label">Topic</div> <div class="field__item"><a href="/news/topics/breaking-research" hreflang="en">Breaking Research</a></div> </div> <div class="field field--name-field-story-tags field--type-entity-reference field--label-hidden field__items"> <div class="field__item"><a href="/news/tags/centre-vaccine-preventable-diseases" hreflang="en">Centre for Vaccine Preventable Diseases</a></div> <div class="field__item"><a href="/news/tags/pediatrics" hreflang="en">Pediatrics</a></div> <div class="field__item"><a href="/news/tags/dalla-lana-school-public-health" hreflang="en">Dalla Lana School of Public Health</a></div> <div class="field__item"><a href="/news/tags/immunology" hreflang="en">Immunology</a></div> <div class="field__item"><a href="/news/tags/vaccines" hreflang="en">Vaccines</a></div> </div> <div class="clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__item"><p>Two new ways to protect children from respiratory syncytial virus, better known as RSV, may soon be available in Canada – and a Ƶ researcher aims to ensure parents can make an informed decision about vaccination.</p> <p>Even though the majority of children will get infected by age 2, “most parents do not know about RSV,” says&nbsp;<a href="https://www.dlsph.utoronto.ca/faculty-profile/fitzpatrick-tiffany/"><strong>Tiffany Fitzpatrick</strong></a>, an assistant professor at the <a href="https://www.dlsph.utoronto.ca/">Dalla Lana School of Public Health</a> and a member of the <a href="https://www.dlsph.utoronto.ca/institutes/centre-for-vaccine-preventable-diseases/">Centre for Vaccine-Preventable Diseases</a>.</p> <p>She’s heard from parents who only learned about the virus – which has a similar seasonal pattern to the flu <a href="https://www.canada.ca/en/public-health/services/diseases/respiratory-syncytial-virus-rsv.html">and&nbsp;symptoms</a>&nbsp;such as coughing, wheezing, and fever – after their child caught it. Although most cases are mild, RSV can lead to more severe illness like pneumonia, and is the leading cause of&nbsp;<a href="https://academic.oup.com/jid/article/226/Supplement_2/S154/6666009">infant hospitalization</a> in Canada&nbsp;and many other countries.</p> <figure role="group" class="caption caption-drupal-media align-left"> <div> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <img loading="lazy" src="/sites/default/files/styles/scale_image_250_width_/public/2023-07/Tiffany-Fitzpatrick-550x906.jpg?itok=jSYxAlS0" width="250" height="412" alt="&quot;&quot;" class="image-style-scale-image-250-width-"> </div> </div> <figcaption><em>Tiffany Fitzpatrick (supplied image)</em></figcaption> </figure> <p>Health Canada is in the process of approving more immunization options to protect children against RSV – an antibody-based drug that may eventually be used to protect all newborns from severe RSV illness and a vaccine for pregnant people that would pass protection from parent to newborn. The potential impact of these new options, both for the health of Canadians and an already overburdened health-care system, is massive.</p> <p>“This could be really revolutionary,” says Fitzpatrick, who is also a scientist at Public Health Ontario.</p> <p>That is, as long as parents have the information necessary to make an informed decision about vaccination and understand the severity of RSV – a task that Fitzpatrick plans to address with her research, recently funded by&nbsp;the <a href="https://cirnetwork.ca/">Canadian Immunization Research Network</a>.</p> <h4>New RSV immunization options coming to Canada</h4> <p>The new RSV prevention drug and vaccine have been a long time coming. Despite more than 60 years of research, options for protecting vulnerable populations (such as newborns) against the virus remained limited – until now.</p> <p>Currently, the only option for protecting newborns at the highest risk of hospitalization (those born very prematurely, born with heart or lung conditions, or those born in remote communities without quick access to medical care) is a monoclonal antibody therapy called palivizumab. The drug cannot treat RSV, but if injected every month during RSV season, it can help prevent severe illness.</p> <p>However, palivizumab comes with a high price tag and needs to be administered every month – sometimes for up to six months – so it is typically reserved for high-risk infants. Health Canada recently approved a longer-acting antibody-based drug, nirsevimab, which would only require one injection per RSV season. Nirsevimab is expected to cost much less than palivizumab, and it may eventually be an option for all parents.</p> <p>A vaccine for pregnant people to help protect newborns from infection is also in the pipeline and may be approved as soon as later this year. The vaccine, recently approved in the U.S. for older adults, offers the prospect of protection against RSV infection – not just disease – to all newborns for the first time.</p> <p>This RSV vaccine, made by Pfizer and known as RSVpreF, would be given to individuals in their late second or third trimester of pregnancy. The vaccine prompts the pregnant person to makes antibodies that are transferred to their fetus, so their child is born with some protection against RSV. In a worldwide, double-blind clinical trial with pregnant women published in&nbsp;<a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2216480"><em>The New England Journal of Medicine</em></a>, the RSVpreF vaccine was more than 81 per cent effective at protecting infants against serious health issues caused by RSV, like lower respiratory tract illness.</p> <figure role="group" class="caption caption-drupal-media align-center"> <div> <div class="field field--name-field-media-image field--type-image field--label-hidden field__item"> <img loading="lazy" src="/sites/default/files/styles/scale_image_750_width_/public/2023-07/Human_Respiratory_Syncytial_Virus_%28RSV%29_%2833114415716%29-crop_0.jpg?itok=b_6QdFMT" width="750" height="500" alt="&quot;&quot;" class="image-style-scale-image-750-width-"> </div> </div> <figcaption><em>Health Canada is on the verge of approving a new drug and a vaccine to protect children from respiratory syncytial virus (RSV), shown here in an electron micrograph image (image by NIAID)</em></figcaption> </figure> <h4>Speaking with parents about RSV and vaccination</h4> <p>In advance of the rollout of nirsevimab and Health Canada’s consideration of RSVpreF data, Fitzpatrick is listening to parents and learning about their understanding of RSV and potential concerns. Her research will involve conducting interviews with parents across Canada and using the information to create tailored educational materials that address questions and provide the information parents may need as they consider their future RSV immunization options.</p> <p>“We need to start planning now to make sure that parents are anticipating this, and they have the information they need to be able to make that decision,” she says.</p> <p>In addition to surveys and interviews, Fitzpatrick and her collaborators will be engaging with populations more vulnerable to RSV. For instance, research indicates that certain living conditions can play a role in a child’s risk for RSV.</p> <p>“We know if a child is exposed to mould, or if they live in a crowded house, they’re much more likely to catch any respiratory virus and for it to become a much more severe disease,” Fitzpatrick says.</p> <p>Specific regions and demographics are also disproportionately impacted by RSV. Collaborators on Fitzpatrick’s study will focus on parents in Nunavut – an area that has the highest rates of RSV hospitalization in the world.</p> <p>“They’re going to be working with community partners there to understand the unique barriers and motivators for RSV immunization in Inuit communities,” she says.</p> <p>Fitzpatrick is aiming to have the educational materials from her study available in time for next year’s RSV season, when nirsevimab and vaccines for pregnant people will hopefully both be available.</p> <p>“I hope this research provides parents with the information that they need to make the decision that’s right for them,” she says, noting that as a public-health practitioner, she ultimately hopes people decide to get immunized “so we can prevent as much RSV disease as possible.”</p> </div> <div class="field field--name-field-news-home-page-banner field--type-boolean field--label-above"> <div class="field__label">News home page banner</div> <div class="field__item">Off</div> </div> Wed, 19 Jul 2023 18:50:09 +0000 siddiq22 302309 at